In glioblastoma, CSCs generate higher levels of the chemoattractants C-C motif chemokine ligand 2 (CCL2), CCL5, vascular endothelial growth factor-A (VEGF-A), and neurotensin than the bulk of the glioma (Yi et al., 2011). Here, CCL2 is linked to central nervous system cancer.